Our nation's efforts to focus attention on the fight both in our country and throughout the globe is important if AIDS is ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

GAITHERSBURG, Md., US, November 7, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways: IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and ...

Funding to fight HIV among gay and bisexual men and transgender women is a fraction of what it should be, researchers said on Tuesday, with advocates blaming stigma for the shortfall.

Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...

The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About ...

Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.

Introduction Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is ...

Overall, tailoring an HIV treatment regimen to individuals’ clinical and social context can help mitigate the persistent barriers to care access. Switching treatment is not just a clinical decision ...

Viral infections, including HIV and influenza, are associated with an increased risk of cardiovascular disease, including coronary heart disease (CHD) and stroke.